Decreased β-cell mass in Hq mutant mice. by Fabienne T. Schulthess (13268705)

Chemotherapy decreases cell proliferation in the adult mouse CNS by Joerg Dietrich (35101)

CHIP overexpression decreases α-syn oligomer levels. by Lorraine V. Kalia (355943)

Loss of Sidt2 decreased insulin granule exocytosis. by Jialin Gao (420257)

Prevalence of changes in smoking habit during COVID19 (n = 851). by Mahmoud A. Alomari (14780446)

Homozygous deletion of <i>ERG251</i> leads to the decreased ergosterol accumulation in the absence of FLC and decreased production of toxic dienol in the presence of FLC. by Xin Zhou (54275)

Decreased diaphragm muscle lateral bifurcations in GAD67-deficient (−/−) E15.5 mice. by Matthew J. Fogarty (283288)

“…<b>D</b> shows a significantly decreased lateral bifurcation number but not medial bifurcation (mean ± SEM) in GAD67-deficient mice compared to wild type (<i>n</i> = 5, *<i>P</i><0.05, unpaired <i>t</i> test). …”

RNF5 loss decreases PEL xenograft tumor growth and cell cycle gene expression. by Xiaojuan Li (351842)

IL-19-/- mice have a decreased inflammatory response to a T cell-dependent challenge of the airways. by Carol Hoffman (196241)

Preoperative and postoperative questionnaire scores of groups A, B, C, D, E, F, and G. by Régis Cohen (11419436)

Subjects:

TG6-44 treatment leads to decrease in A/X31-induced cell death in THP-1 cells. by Juan A. De La Cruz (11154187)

sC5b-9 patients decrease in patients treated with mycophenolate mofetil. by Joshua M. Thurman (517193)

“…(C) The levels of sC5b-9 decreased over time (P < 0.001 by linear regression; n = 19 for all time-points). …”

TPP decreases melanoma tumor growth rate when administered via hydrogel. by Kyle C. Kloepping (9928265)

TG6-44 treatment decreases IFN-β levels in A/X31-infected THP-1 cells. by Juan A. De La Cruz (11154187)

CC-1⁺ immunostained cell numbers decrease by 2 days after TBI and return to control levels by 5 weeks. by Krista A. Dent (709531)

“…Panels show contralateral (Contra) and ipsilateral (Ipsi) external capsule (EC) at (A,B) 2 days (2d), (C,D) 2 weeks (2w) and (E,F) 5 weeks (5w) (G) In the external capsule numbers of CC-1⁺ oligodendrocytes were decreased by 2d after injury, remained decreased at 2 weeks and returned to normal levels by 5 weeks. …”

<i>Dmd^mdx</i> rats are characterized by muscle weakness and by a decrease in a spontaneous activity. by Thibaut Larcher (331981)

“…<i>Dmd^mdx</i> rats showed fatigue with a decreased force grip across the five pulls, and significant values are obtained for the two last trials that were reduced to ∼70% when compared to Trial 1. …”

Study Flow Diagram. by Elizabeth S. Munroe (21568166)

Subjects:

Antibody and antigen responses to Lufotrelvir vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

Subjects:

Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments). by Elizabeth S. Munroe (21568166)

Subjects:

Antibody and antigen responses to Ensovibep vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

Subjects: